![Cameron McDonough](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cameron McDonough
Amministratore Delegato presso GENERATION BIO CO.
Patrimonio netto: 6 M $ in data 31/05/2024
Profilo
Cameron Geoffrey McDonough is the founder of Catalyst Medical Solutions, Inc. He currently holds the position of President, Chief Executive Officer & Director at Generation Bio Co. and Independent Director at Third Harmonic Bio, Inc. He is also an Advisor at Atlas Venture Advisors, Inc. Previously, he served as President & Chief Executive Officer at Swedish Orphan Biovitrum AB from 2011 to 2017.
He was also an Independent Director at PTC Therapeutics, Inc. from 2013 to 2017.
Additionally, he served as an Independent Director at Zafgen, Inc. Furthermore, he held the position of Independent Non-Executive Director at Surface Oncology, Inc. from 2018 to 2022.
Prior to that, he was the President-Europe, Middle East & Africa Region at Genzyme Corp.
from 2002 to 2011.
Mr. McDonough received his undergraduate degree from The University of North Carolina at Chapel Hill and his graduate degree from Harvard Medical School in 1997.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
GENERATION BIO CO.
2.74% | 15/04/2024 | 1 824 920 ( 2.74% ) | 6 M $ | 31/05/2024 |
THIRD HARMONIC BIO, INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Cameron McDonough
Società | Posizione | Inizio |
---|---|---|
GENERATION BIO CO. | Amministratore Delegato | 01/10/2017 |
THIRD HARMONIC BIO, INC. | Direttore/Membro del Consiglio | 28/03/2024 |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consulente / Consigliere | - |
Precedenti posizioni note di Cameron McDonough
Società | Posizione | Fine |
---|---|---|
SURFACE ONCOLOGY, INC. | Direttore/Membro del Consiglio | 28/02/2022 |
PTC THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/09/2017 |
SWEDISH ORPHAN BIOVITRUM AB | Amministratore Delegato | 22/05/2017 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Catalyst Medical Solutions, Inc. | Fondatore | - |
Formazione di Cameron McDonough
Harvard Medical School | Graduate Degree |
The University of North Carolina at Chapel Hill | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
GENERATION BIO CO. | Health Technology |
THIRD HARMONIC BIO, INC. | Health Technology |
Aziende private | 5 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Zafgen, Inc.
![]() Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Catalyst Medical Solutions, Inc. | |
Surface Oncology, Inc.
![]() Surface Oncology, Inc. BiotechnologyHealth Technology Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114). Its pipeline also includes licensed product programs, such as a collaboration with Novartis targeting CD73 (NZV930, Phase 1) and a collaboration with GlaxoSmithKline targeting PVRIG (SRF813, preclinical). The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Borsa valori
- Insiders
- Cameron McDonough